These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9867168)

  • 1. Prevalence of adverse reactions to positron emitting radiopharmaceuticals in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine.
    Silberstein EB
    J Nucl Med; 1998 Dec; 39(12):2190-2. PubMed ID: 9867168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of adverse reactions in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine.
    Silberstein EB; Ryan J
    J Nucl Med; 1996 Jan; 37(1):185-92. PubMed ID: 8543992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of adverse events to radiopharmaceuticals from 2007 to 2011.
    Silberstein EB
    J Nucl Med; 2014 Aug; 55(8):1308-10. PubMed ID: 24876206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear medicine practice in Japan: a report of the sixth nationwide survey in 2007.
    Kuwabara Y; Koizumi K; Ushijima Y; Kinuya S; Kinomura S; Suga K; Takeoka H; Takeda T; Toyama H; Arao Y; Nishiyama Y; Murakami K; Morita K
    Ann Nucl Med; 2009 Feb; 23(2):209-15. PubMed ID: 19225946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospective survey on adverse effects of radiopharmaceuticals].
    Bagheri H; Galian ME; Bastie D; Couffignal AL; Tafani JA; Fourcade C; Morena I; Guiraud R; Montastruc JL
    Therapie; 1996; 51(5):550-3. PubMed ID: 9138391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full report on a survey of adverse reactions to radiopharmaceuticals from 1975 to 2017 in Japan.
    Matsuda H; Uehara T; Okazawa H; Mizumura S; Yokoyama K; Yoshimura M;
    Ann Nucl Med; 2020 Apr; 34(4):299-304. PubMed ID: 31989466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administered radiopharmaceutical doses in children: a survey of 13 pediatric hospitals in North America.
    Treves ST; Davis RT; Fahey FH
    J Nucl Med; 2008 Jun; 49(6):1024-7. PubMed ID: 18483096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A portable database of adverse reactions and drug interactions with radiopharmaceuticals.
    Gómez Perales JL; Martínez AA
    J Nucl Med Technol; 2013 Sep; 41(3):212-5. PubMed ID: 23857419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography: a technology assessment of PET imaging--past, present, and future.
    Frazee D
    Radiol Manage; 2004; 26(6):38-43. PubMed ID: 15633509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying Image Gently SM and Image Wisely SM in nuclear medicine.
    Jafari ME; Daus AM
    Health Phys; 2013 Feb; 104(2 Suppl 1):S31-6. PubMed ID: 23287517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of PET activity in Germany during 1999.
    Brix G; Nosske D; Glatting G; Minkov V; Reske SN
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1091-7. PubMed ID: 12173024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of radioactive substances in nuclear medicine research: current trends and radiation exposure of study subjects].
    Minkov V; Schwarz ER; Bauer B; Nosske D; Erzberger A; Brix G
    Nuklearmedizin; 2001 Aug; 40(4):116-21. PubMed ID: 11556201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The 36th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 39th Survey in 2013)].
    Matsuda H; Arano Y; Okazawa H; Mizumura S; Yokoyama K; Yoshimura M
    Kaku Igaku; 2015 Feb; 52(1):1-12. PubMed ID: 26502668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation safety considerations for PET centers.
    Brown TF; Yasillo NJ
    J Nucl Med Technol; 1997 Jun; 25(2):98-102; quiz 104-5. PubMed ID: 9239612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Instrumentation and radiopharmaceutical validation.
    Zigler SS
    Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):402-10. PubMed ID: 19834450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Radiopharmaceutical Adverse Reaction Reports to the British Nuclear Medicine Society from 2007 to 2016.
    Kennedy-Dixon TG; Gossell-Williams M; Cooper M; Trabelsi M; Vinjamuri S
    J Nucl Med; 2017 Dec; 58(12):2010-2012. PubMed ID: 28522742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The 27th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (the 30th survey in 2004)].
    Kusakabe K; Okamura T; Kasagi K; Komatani A; Sato Y; Matsuda H; Maruno H; ;
    Kaku Igaku; 2006 Feb; 43(1):23-35. PubMed ID: 16634540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strengthening radiopharmacy practice in IAEA Member States.
    Duatti A; Bhonsle U
    Semin Nucl Med; 2013 May; 43(3):188-94. PubMed ID: 23561456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Future prospects for nuclear medicine].
    Senda K; Tonami N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Oct; 55(13):508-16. PubMed ID: 8721345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.